Here are the facts.Lynette Ousby resigned on 11 December 2023 -...

Here are the facts.

Lynette Ousby resigned on 11 December 2023 - refer below.

Situation is not ideal, given the UK market is what's dragging Alcidion.But to be fair to Alcidion, Lynette's departure is not required to be disclosed to the market. Continuous disclosure only applies to change of chair, director, CEO, CFO and company secretary.

I am assuming the company would make an announcement about potential replacement/situation soon. But to b fair, the timing did not help given the festive seasons etc.

From my perspective, I have always thought Lynette was brought in to lead Alcidion into phase 2 of the UK market penetration strategy. Problem is we are still stuck in phase 1.

Irrespective of the reason for Lynette's departure, this is an opportunity to reset things. My ideal sort of communication from Alcidion is to acknowledge the uncertainties in UK, importance of cash preservation and reviewing whether their current strategy is still fit for purpose. They should not rush into appointing another UK MD just for the sake of it if it is no longer currently required at this point in time.